WO2007062335A8 - New pleuromutilin derivative and its use - Google Patents

New pleuromutilin derivative and its use

Info

Publication number
WO2007062335A8
WO2007062335A8 PCT/US2006/061068 US2006061068W WO2007062335A8 WO 2007062335 A8 WO2007062335 A8 WO 2007062335A8 US 2006061068 W US2006061068 W US 2006061068W WO 2007062335 A8 WO2007062335 A8 WO 2007062335A8
Authority
WO
WIPO (PCT)
Prior art keywords
compound
skin
pleuromutilin derivative
respiratory tract
structure infections
Prior art date
Application number
PCT/US2006/061068
Other languages
French (fr)
Other versions
WO2007062335A3 (en
WO2007062335A2 (en
Inventor
Ann Marie Diederich
Joseph Sisko
Frederick G Vogt
Original Assignee
Glaxo Group Ltd
Ann Marie Diederich
Joseph Sisko
Frederick G Vogt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Ann Marie Diederich, Joseph Sisko, Frederick G Vogt filed Critical Glaxo Group Ltd
Publication of WO2007062335A2 publication Critical patent/WO2007062335A2/en
Publication of WO2007062335A3 publication Critical patent/WO2007062335A3/en
Publication of WO2007062335A8 publication Critical patent/WO2007062335A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/66—Y being a hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention is directed to the succinate salt of trans-4-aminocyclohexyl (1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramenthyl-9-oxotricyclo[5.4.3.01,8]tetradec-6-yl imidodicarbonate (Compound IA). Compound IA is useful for the treatment of a variety of diseases and conditions, such as respiratory tract and skin and skin structure infections. Accordingly, the invention is still further directed to methods of treating respiratory tract and skin and skin structure infections using Compound IA or a pharmaceutical composition comprising Compound IA.
PCT/US2006/061068 2005-11-18 2006-11-18 New pleuromutilin derivative and its use WO2007062335A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73820305P 2005-11-18 2005-11-18
US60/738,203 2005-11-18

Publications (3)

Publication Number Publication Date
WO2007062335A2 WO2007062335A2 (en) 2007-05-31
WO2007062335A3 WO2007062335A3 (en) 2007-11-29
WO2007062335A8 true WO2007062335A8 (en) 2008-07-10

Family

ID=38068018

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2006/061067 WO2007062334A2 (en) 2005-11-18 2006-11-18 New pleuromutilin derivative and its use
PCT/US2006/061068 WO2007062335A2 (en) 2005-11-18 2006-11-18 New pleuromutilin derivative and its use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2006/061067 WO2007062334A2 (en) 2005-11-18 2006-11-18 New pleuromutilin derivative and its use

Country Status (3)

Country Link
PE (1) PE20070825A1 (en)
TW (1) TW200738599A (en)
WO (2) WO2007062334A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101671367B (en) * 2008-09-12 2012-09-05 中国科学院上海药物研究所 Pleuromutilin phosphate compounds, medicinal composition thereof, preparation method thereof and application thereof
JP2010100582A (en) * 2008-10-24 2010-05-06 Kyorin Pharmaceut Co Ltd Mutilin derivative containing heteroaromatic ring carboxylic acid structure at 14-position substituent
CN103641702B (en) * 2013-11-18 2015-11-18 宁夏泰瑞制药股份有限公司 A kind of method for hydrolysis of pleuromutilin
TWI762573B (en) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 Purification of pleuromutilin
EP4338732A1 (en) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of tularemia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060542A (en) * 1969-07-25 1977-11-29 Biochemie Gesellschaft M.B.H. 14-Desoxy-14 thiocyanato-acetoxy-mutilin
US4086359A (en) * 1975-09-30 1978-04-25 E. R. Squibb & Sons, Inc. Derivatives of pleuromutilin and compositions
US20030219461A1 (en) * 2000-09-12 2003-11-27 Britten Nancy J. Parenteral combination therapy for infective conditions
GB0024811D0 (en) * 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
US6750064B2 (en) * 2000-12-28 2004-06-15 S.S.C.I. Inc. Methods of screening for possible solid forms

Also Published As

Publication number Publication date
WO2007062335A3 (en) 2007-11-29
PE20070825A1 (en) 2007-08-05
WO2007062334A2 (en) 2007-05-31
TW200738599A (en) 2007-10-16
WO2007062334A8 (en) 2007-12-21
WO2007062335A2 (en) 2007-05-31
WO2007062334A3 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
WO2006059234A3 (en) Bicyclic amides as kinase inhibitors
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
WO2004071400A3 (en) Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
ATE442142T1 (en) FREDERICAMYCIN DERIVATIVES AS DRUGS FOR TUMOR TREATMENT
EP2338878A3 (en) N-hydroxyamide derivatives possessing antibacterial activity
WO2004037789A8 (en) Methylene urea derivatives as raf-kinase inhibitors
WO2007062333A3 (en) New pleuromutilin derivative and its use
WO2006085113A3 (en) 2-substituted 5-membered heteroaryl carboxylates as hm74a receptor agonists
WO2006124413A3 (en) Methods for treating drug resistant cancer
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
WO2005016867A3 (en) Anthranilic acid derivatives and their use as activators of the hm74a receptor
WO2010107807A3 (en) Compounds for treating inflammation and pain
WO2007062335A3 (en) New pleuromutilin derivative and its use
WO2009003719A3 (en) Indane-amine derivatives, their preparation and use as medicaments
WO2004091591A3 (en) Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
BR0307588A (en) Compound, gsk-3 inhibitor, pharmaceutical composition, and therapeutic or preventative agent for a disease
MX2012001529A (en) 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives as c-met tyrosine kinase modulators.
WO2006088945A3 (en) Granulysin peptides and methods of use thereof
WO2004087700A8 (en) Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
EP2801359A3 (en) The use of nicotine for the treatment of sepsis in humans caused by antibiotic
EA200870223A1 (en) DERIVATIVES OF BENZOIZOINDOL FOR THE TREATMENT OF PAIN
WO2006002846A3 (en) New analogs of nitrobenzylthioinosine
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06839947

Country of ref document: EP

Kind code of ref document: A2